Regulation of Insulin Signaling and Glucose Transporter 4 (GLUT4) Exocytosis by Phosphatidylinositol 3,4,5-trisphosphate (PIP3) Phosphatase, Skeletal Muscle, and Kidney Enriched Inositol Polyphosphate Phosphatase (SKIP)

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2012 Jan 17

PMID 22247557

Citations 21

Authors

Takeshi Ijuin

Tadaomi Takenawa

Affiliations

Soon will be listed here.

Abstract

The glucose transporter 4 (GLUT4) is responsible for glucose uptake in the skeletal muscle. Insulin-induced translocation of GLUT4 to the plasma membrane requires phosphatidylinositol 3-kinase activation-mediated generation of phosphatidylinositol 3,4,5-trisphosphate PIP(3) and subsequent activation of Akt. Previous studies suggested that skeletal muscle and kidney enriched inositol polyphosphate phosphatase (SKIP) has negative effects on the regulation of insulin signaling in the skeletal muscle cells. Here, we compared its effects on insulin signaling by selective inhibition of SKIP, SHIP2, and phosphatase and tensin homologue on chromosome 10 (PTEN) by short interfering RNA in the C2C12 myoblast cells. Suppression of SKIP significantly increased the insulin-stimulated phosphatidylinositol 3,4,5-trisphosphate levels and Akt phosphorylation. Furthermore, silencing of SKIP, but not of PTEN, increased the insulin-dependent recruitment of GLUT4 vesicles to the plasma membrane. Taken together, these results imply that SKIP negatively regulates insulin signaling and glucose uptake by inhibiting GLUT4 docking and/or fusion to the plasma membrane.

Citing Articles

Modulating PAK1: Accessory Proteins as Promising Therapeutic Targets.

Mirzaiebadizi A, Shafabakhsh R, Ahmadian M Biomolecules. 2025; 15(2).

PMID: 40001545 PMC: 11852631. DOI: 10.3390/biom15020242.

Study of the Effects of Deuterium-Depleted Water on the Expression of GLUT4 and Insulin Resistance in the Muscle Cell Line C2C12.

Kondo M, Sawada K, Matsuda Y, Abe M, Sanechika N, Takanashi Y Biomedicines. 2024; 12(8).

PMID: 39200235 PMC: 11351524. DOI: 10.3390/biomedicines12081771.

Mechanism of muscle atrophy in a normal-weight rat model of type 2 diabetes established by using a soft-pellet diet.

Akieda-Asai S, Ma H, Han W, Nagata J, Yamaguchi F, Date Y Sci Rep. 2024; 14(1):7670.

PMID: 38561446 PMC: 10984920. DOI: 10.1038/s41598-024-57727-2.

The Comparative Effects of Myo-Inositol and Metformin Therapy on the Clinical and Biochemical Parameters of Women of Normal Weight Suffering from Polycystic Ovary Syndrome.

Gudovic A, Bukumiric Z, Milincic M, Pupovac M, Andjic M, Ivanovic K Biomedicines. 2024; 12(2).

PMID: 38397951 PMC: 10886614. DOI: 10.3390/biomedicines12020349.

Myo-Inositol and D-Chiro-Inositol as Modulators of Ovary Steroidogenesis: A Narrative Review.

Bizzarri M, Monti N, Piombarolo A, Angeloni A, Verna R Nutrients. 2023; 15(8).

PMID: 37111094 PMC: 10145676. DOI: 10.3390/nu15081875.

References

Nakashima N, Sharma P, Imamura T, Bookstein R, Olefsky J . The tumor suppressor PTEN negatively regulates insulin signaling in 3T3-L1 adipocytes. J Biol Chem. 2000; 275(17):12889-95. DOI: 10.1074/jbc.275.17.12889. View

Kurlawalla-Martinez C, Stiles B, Wang Y, Devaskar S, Kahn B, Wu H . Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue. Mol Cell Biol. 2005; 25(6):2498-510. PMC: 1061603. DOI: 10.1128/MCB.25.6.2498-2510.2005. View

Saltiel A . New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell. 2001; 104(4):517-29. DOI: 10.1016/s0092-8674(01)00239-2. View

Sasaoka T, Hori H, Wada T, Ishiki M, HARUTA T, Ishihara H . SH2-containing inositol phosphatase 2 negatively regulates insulin-induced glycogen synthesis in L6 myotubes. Diabetologia. 2001; 44(10):1258-67. DOI: 10.1007/s001250100645. View

Ijuin T, Yu Y, Mizutani K, Pao A, Tateya S, Tamori Y . Increased insulin action in SKIP heterozygous knockout mice. Mol Cell Biol. 2008; 28(17):5184-95. PMC: 2519744. DOI: 10.1128/MCB.01990-06. View

Chung J, Grammer T, Lemon K, Kazlauskas A, Blenis J . PDGF- and insulin-dependent pp70S6k activation mediated by phosphatidylinositol-3-OH kinase. Nature. 1994; 370(6484):71-5. DOI: 10.1038/370071a0. View

Serunian L, Auger K, Cantley L . Identification and quantification of polyphosphoinositides produced in response to platelet-derived growth factor stimulation. Methods Enzymol. 1991; 198:78-87. DOI: 10.1016/0076-6879(91)98010-4. View

Van Weeren P, de Bruyn K, Van Lint J, Burgering B . Essential role for protein kinase B (PKB) in insulin-induced glycogen synthase kinase 3 inactivation. Characterization of dominant-negative mutant of PKB. J Biol Chem. 1998; 273(21):13150-6. DOI: 10.1074/jbc.273.21.13150. View

Garofalo R, Orena S, Rafidi K, Torchia A, Stock J, Hildebrandt A . Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta. J Clin Invest. 2003; 112(2):197-208. PMC: 164287. DOI: 10.1172/JCI16885. View

10.

Sano H, Kane S, Sano E, Miinea C, Asara J, Lane W . Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. J Biol Chem. 2003; 278(17):14599-602. DOI: 10.1074/jbc.C300063200. View

11.

Ijuin T, Takenawa T . SKIP negatively regulates insulin-induced GLUT4 translocation and membrane ruffle formation. Mol Cell Biol. 2003; 23(4):1209-20. PMC: 141139. DOI: 10.1128/MCB.23.4.1209-1220.2003. View

12.

Dugani C, Klip A . Glucose transporter 4: cycling, compartments and controversies. EMBO Rep. 2005; 6(12):1137-42. PMC: 1369215. DOI: 10.1038/sj.embor.7400584. View

13.

Stiles B, Wang Y, Stahl A, Bassilian S, Lee W, Kim Y . Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity [corrected]. Proc Natl Acad Sci U S A. 2004; 101(7):2082-7. PMC: 357055. DOI: 10.1073/pnas.0308617100. View

14.

Koumanov F, Jin B, Yang J, Holman G . Insulin signaling meets vesicle traffic of GLUT4 at a plasma-membrane-activated fusion step. Cell Metab. 2005; 2(3):179-89. DOI: 10.1016/j.cmet.2005.08.007. View

15.

Cho H, Mu J, Kim J, Thorvaldsen J, Chu Q, Crenshaw 3rd E . Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science. 2001; 292(5522):1728-31. DOI: 10.1126/science.292.5522.1728. View

16.

Farese R, Sajan M, Standaert M . Atypical protein kinase C in insulin action and insulin resistance. Biochem Soc Trans. 2005; 33(Pt 2):350-3. DOI: 10.1042/BST0330350. View

17.

Thong F, Dugani C, Klip A . Turning signals on and off: GLUT4 traffic in the insulin-signaling highway. Physiology (Bethesda). 2005; 20:271-84. DOI: 10.1152/physiol.00017.2005. View

18.

Sleeman M, Wortley K, Lai K, Gowen L, Kintner J, Kline W . Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity. Nat Med. 2005; 11(2):199-205. DOI: 10.1038/nm1178. View

19.

Ijuin T, Mochizuki Y, Fukami K, Funaki M, Asano T, Takenawa T . Identification and characterization of a novel inositol polyphosphate 5-phosphatase. J Biol Chem. 2001; 275(15):10870-5. DOI: 10.1074/jbc.275.15.10870. View

20.

Ng Y, Ramm G, Lopez J, James D . Rapid activation of Akt2 is sufficient to stimulate GLUT4 translocation in 3T3-L1 adipocytes. Cell Metab. 2008; 7(4):348-56. DOI: 10.1016/j.cmet.2008.02.008. View